CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 7 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Bay Capital Management LP | 2,149,187 | $1,204,000 | 0.03% |
| BEAM WEALTH ADVISORS, INC. | 17,000 | $10,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 17,367 | $10,000 | 0.00% |
| Citadel Advisors | 24,312 | $14,000 | 0.00% |
| Renaissance Technologies | 598,741 | $335,000 | 0.00% |
| UBS Group AG | 20,000 | $11,000 | 0.00% |